Table 1

Clinical and laboratory variables of studied groups
Ovarian cancer (n = 30) Benign gynecological (n = 20) Controls (n = 20) p (ANOVA)
Age (range) 24-73 40-60 30-66 -
Menopause% 30 25 20 -
RBCs count x1012/l 4.5 ± 0.5 4.5 ±0.49 4.8 ± 0.5 NS
Hb g/dl 12.1 ± 1.5 12.5 ± 1.4 12 ± 1.3 NS
WBCs x109/l 8.1 ± 2.9 6.9 ± 2.3 7.6 ± 2 NS
Platelets x109/l 270 ± 82 294.7 ± 72.1 264.7 ± 59.4 NS
S.glucose (mg/dl) 95 ± 15.4 91 ± 7.4 85 ± 9.4 NS
S.urea (mg/dl) 31.4 ± 8.9 29.1 ± 6.7 27.9 ± 7.9 NS
S.creatinine (mg/dl) 0.7 ± 0.15 0.7 ± 0.13 0.73 ± 0.12 NS
ALT (U/l) 17.4 ± 12.6 15.4 ± 11.5 13.9 ± 7.2 NS
AST (U/l) 24.7 ± 14.5 21.1 ± 10.4 21.1 ± 6.1 NS
ALP (U/l) 76.4 ± 24.2 68.5 ± 10.9 70.5 ± 11.3 NS
Total protein g/dl 7.6 ± 0.6 7.4 ± 0.5 7.7 ± 0.53 NS
Albumin g/dl 3.8 ± 0.33 3.9 ± 0.36 3.9 ± 0.29 NS
Total bilirubin mg/dl 0.46 ± 0.3 0.6 ± 0.26 0.5 ± 0.24 NS
D. bilirubin mg/dl 0.12 ± 0.07 0.11 ± 0.06 0.1 ± 0.06 NS
CA125 U/ml 295.5 (4.2-1781)b,c 26.9 (9.4-553)a 12.5 (4.1-34.3) <0.001
HE4 pmol/l 237.2 (34.3-4090)b,c 66.1 (24.8-179.2) 56.9 (20.8-111.6) <0.001

Values are expressed as the mean ± standard deviation or median (range). aP < 0.05, bP < 0.001,with respect to the control group; cP = 0.001, with respect to benign gynecological dis.

Hamed et al.

Hamed et al. Diagnostic Pathology 2013 8:11   doi:10.1186/1746-1596-8-11

Open Data